Pattra Chun-on, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Telomere-Binding Proteins | 2 | 2024 | 119 | 1.010 |
Why?
|
Telomerase | 2 | 2024 | 745 | 0.740 |
Why?
|
Promoter Regions, Genetic | 2 | 2022 | 5789 | 0.450 |
Why?
|
Telomere | 2 | 2024 | 941 | 0.280 |
Why?
|
Melanoma | 1 | 2022 | 5709 | 0.230 |
Why?
|
Skin Neoplasms | 1 | 2022 | 5819 | 0.210 |
Why?
|
Pulmonary Surfactant-Associated Protein C | 1 | 2020 | 30 | 0.180 |
Why?
|
Integrases | 1 | 2020 | 516 | 0.150 |
Why?
|
Transgenes | 1 | 2020 | 1010 | 0.140 |
Why?
|
Transcriptional Activation | 1 | 2022 | 1756 | 0.130 |
Why?
|
Pedigree | 1 | 2024 | 4589 | 0.130 |
Why?
|
Hepatitis B, Chronic | 1 | 2016 | 410 | 0.100 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2022 | 8545 | 0.070 |
Why?
|
Cell Line, Tumor | 1 | 2022 | 16979 | 0.060 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2016 | 2298 | 0.060 |
Why?
|
Liver Neoplasms | 1 | 2016 | 4320 | 0.040 |
Why?
|
Telomeric Repeat Binding Protein 2 | 1 | 2020 | 20 | 0.040 |
Why?
|
Genes, Lethal | 1 | 2020 | 225 | 0.040 |
Why?
|
Spermatogenesis | 1 | 2020 | 259 | 0.040 |
Why?
|
Mutation | 1 | 2022 | 30045 | 0.040 |
Why?
|
Testis | 1 | 2020 | 794 | 0.030 |
Why?
|
Genes, Reporter | 1 | 2020 | 1529 | 0.030 |
Why?
|
alpha-Fetoproteins | 1 | 2016 | 223 | 0.030 |
Why?
|
Base Sequence | 1 | 2024 | 12450 | 0.030 |
Why?
|
Cell Lineage | 1 | 2020 | 2555 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2020 | 2734 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2020 | 6532 | 0.020 |
Why?
|
Alleles | 1 | 2020 | 6922 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2020 | 3612 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2449 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2020 | 9535 | 0.020 |
Why?
|
Liver Cirrhosis | 1 | 2016 | 1934 | 0.020 |
Why?
|
Humans | 4 | 2024 | 761423 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2020 | 12796 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2016 | 3057 | 0.010 |
Why?
|
Ultrasonography | 1 | 2016 | 5970 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16606 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2020 | 22163 | 0.010 |
Why?
|
Lung | 1 | 2020 | 9995 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 14664 | 0.010 |
Why?
|
Mass Screening | 1 | 2016 | 5428 | 0.010 |
Why?
|
Male | 3 | 2024 | 360736 | 0.010 |
Why?
|
Female | 3 | 2024 | 392581 | 0.010 |
Why?
|
Adult | 2 | 2024 | 221148 | 0.010 |
Why?
|
Mice | 1 | 2020 | 81509 | 0.010 |
Why?
|
Young Adult | 1 | 2016 | 59207 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2016 | 64651 | 0.010 |
Why?
|
Animals | 1 | 2020 | 168441 | 0.000 |
Why?
|
Aged | 1 | 2016 | 169235 | 0.000 |
Why?
|
Middle Aged | 1 | 2016 | 220826 | 0.000 |
Why?
|